NCT00183820 2017-07-07
Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma
University of Southern California
Phase 2 Completed
University of Southern California
National Cancer Institute (NCI)
National Cancer Institute (NCI)